Literature DB >> 30406498

Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study.

Cindy Tiseo1, Antonio Carolei2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30406498     DOI： 10.1007/s11739-018-1978-8

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  12 in total

1.  Oral anticoagulants for stroke prevention in patients with atrial fibrillation and previous intracranial hemorrhage.

Authors:  Simone Birocchi; Gian Marco Podda
Journal:  Intern Emerg Med       Date:  2016-11-04       Impact factor: 3.397

2.  Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture.

Authors:  David M Hasan; Kelly B Mahaney; Robert D Brown; Irene Meissner; David G Piepgras; John Huston; Ana W Capuano; James C Torner
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

3.  Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study.

Authors:  Carmelo Lucio Sturiale; Fabrizio Pignotti; Marzia Giordano; Angelo Porfidia; Alessio Albanese; Igor Giarretta; Alfredo Puca; Eleonora Gaetani; Sonia D'Arrigo; Ada Truma; Alessandro Olivi; Roberto Pola
Journal:  Intern Emerg Med       Date:  2018-07-30       Impact factor: 3.397

4.  The clinical dilemma of treating transient ischaemic attack-like symptoms in patients with coexisting arteriovenous malformation.

Authors:  Edwin Jabbari; Sakthivel Sethuraman; Lakshmanan Sekaran
Journal:  BMJ Case Rep       Date:  2014-03-11

Review 5.  Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  Colin P Derdeyn; Gregory J Zipfel; Felipe C Albuquerque; Daniel L Cooke; Edward Feldmann; Jason P Sheehan; James C Torner
Journal:  Stroke       Date:  2017-06-22       Impact factor: 7.914

6.  Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations.

Authors:  Hans-Martin Schneble; Aicha Soumare; Dominique Hervé; Damien Bresson; Jean-Pierre Guichard; Florence Riant; Elisabeth Tournier-Lasserve; Christophe Tzourio; Hugues Chabriat; Christian Stapf
Journal:  Stroke       Date:  2012-11-13       Impact factor: 7.914

Review 7.  Natural history of cerebral arteriovenous malformations: a meta-analysis.

Authors:  Bradley A Gross; Rose Du
Journal:  J Neurosurg       Date:  2012-11-30       Impact factor: 5.115

8.  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial.

Authors:  J P Mohr; Michael K Parides; Christian Stapf; Ellen Moquete; Claudia S Moy; Jessica R Overbey; Rustam Al-Shahi Salman; Eric Vicaut; William L Young; Emmanuel Houdart; Charlotte Cordonnier; Marco A Stefani; Andreas Hartmann; Rüdiger von Kummer; Alessandra Biondi; Joachim Berkefeld; Catharina J M Klijn; Kirsty Harkness; Richard Libman; Xavier Barreau; Alan J Moskowitz
Journal:  Lancet       Date:  2013-11-20       Impact factor: 79.321

9.  Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors.

Authors:  Helen Kim; Rustam Al-Shahi Salman; Charles E McCulloch; Christian Stapf; William L Young
Journal:  Neurology       Date:  2014-07-11       Impact factor: 9.910

10.  Treatment of Brain AVMs (TOBAS): study protocol for a pragmatic randomized controlled trial.

Authors:  Tim E Darsaut; Elsa Magro; Jean-Christophe Gentric; André Lima Batista; Chiraz Chaalala; David Roberge; Michel W Bojanowski; Alain Weill; Daniel Roy; Jean Raymond
Journal:  Trials       Date:  2015-11-04       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.